The natural history of complex regional pain syndrome

Clinical Journal of Pain

Volumn 25, Issue 4, 2009, Pages 273-280

  Schwartzman, Robert J ^a   Erwin, Kirsten L ^a   Alexander, Guillermo M ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Complex regional pain syndrome (CRPS); Disease progression; Natural history; Questionnaire

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BACLOFEN; MORPHINE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SEDATIVE AGENT; STEROID;

ADOLESCENT; ADULT; AGED; ANALGESIA; ARTICLE; CHILD; CLINICAL FEATURE; COMORBIDITY; COMPLEX REGIONAL PAIN SYNDROME; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; PAIN ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCHOOL CHILD; SKIN COLOR; SPINAL CORD STIMULATION; SWEATING;

EID: 67649553641     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e31818ecea5     Document Type: Article

References (60)

1. Schwartzman RJ, Grothusen J, Kiefer TR, et al. Neuropathic central pain: epidemiology, etiology, and treatment options. Arch Neurol. 2001;58:1547-1550.
2. Janig W, Baron R. Complex regional pain syndrome: mystery explained? Lancet Neurol. 2003;2:687-697.
3. Marchand F, Perretti M, McMahon SB. Role of the immune system in chronic pain. Nat Rev Neurosci. 2005;6:521-532.
4. Watkins LR, Maier SF. Immune regulation of central nervous system functions: from sickness responses to pathological pain. J Intern Med. 2005;257:139-155.
5. Harden RN, Bruehl S, Galer BS, et al. Complex regional pain syndrome: are the IASP diagnostic criteria valid and sufficiently comprehensive? Pain. 1999;83:211-219.
6. Bruehl S, Harden RN, Galer BS, et al. External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria. International Association for the Study of Pain. Pain. 1999;81:147-154.
7. Harden NR, Bruehl S. Diagnostic criteria: the statistical derivation of the four criterion factors. In: Wilson PR, Stanton- Hicks MD, Harden RN, eds. CRPS: Current Diagnosis and Therapy. Seattle, Washington: IASP Press; 2005:45-58.
8. Orner GC, Thomas MS. Treatment of causalgia. Tex Med. 1971;67:93-96.
9. Bohm E. Das Sudecksche Syndrome. Hefte zur Unfallheilkunde. 1985;174:241-250.
10. Atkins RM, Duckworth T, Karis JA. Features of algodystrophy after Colles' fracture. J Bone Joint Surg. 1990;72:105-110.
11. Veldman PH, Reynen HM, Arntz IE, et al. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet. 1993;342:1012-1016.
12. Stanton-Hicks M, Jänig W, Hassenbusch S, et al. Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain. 1995;63:127-133.
13. Birklein F, Riedl B, Sieweke N, et al. Neurological findings in complex regional pain syndromes-analysis of 145 cases. Acta Neurol Scand. 2000;101:262-269.
14. Dijkstra PU, Groothoff JW, ten Duis HJ, et al. Incidence of complex regional pain syndrome type I after fractures of the distal radius. Eur J Pain. 2003;7:457-462.
15. Bickerstaff DR, Kanis JA. Algodystrophy: an under-recognized complication of minor trauma. Br J Rheumatol. 1994;33: 240-248.
16. Zyluk A. The natural history of post-traumatic reflex sympathetic dystrophy. J Hand Surg. 1998;23:20-23.
17. de Mos M, de Bruijn AG, Huygen FJ, et al. The incidence of complex regional pain syndrome: a population-based study. Pain. 2007;129:12-20.
18. Sandroni P, Berud-Larson L, McClelland RL, et al. Complex regional pain syndrome type I: incidence and prevalence in Olmsted County, a population-based study. Pain. 2003;103:199-207.
19. Melzack R. The short-form McGill Pain Questionnaire. Pain. 1987;30:191-197.
20. Allen G, Galer BS, Schwartz L. Epidemiology of complex regional pain syndrome: a retrospective chart review of 134 patients. Pain. 1999;80:539-544.
21. Schwartzman RJ, McLellan TL. Reflex sympathetic dystrophy. A review. Arch Neurol. 1987;44:555-561.
22. Waxman SG, Dib-Hajj S, Cummins TR, et al. Sodium channels and pain. Proc Natl Acad Sci USA. 1999;96: 7635-7639.
23. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science. 2000;288:1765-1769.
24. Schwartzman RJ, Alexander GM, Grothusen J. Pathophysiology of complex regional pain syndrome. Expert Rev Neurother. 2006;6:669-681.
25. Birklein F, Rowbotham MC. Does pain change the brain? Neurology. 2005;65:666-667.
26. Bej MD, Schwartzman RJ. Abnormalities of cutaneous blood flow regulation in patients with reflex sympathetic dystrophy as measured by laser Doppler fluxmetry. Arch Neurol. 1991;48: 912-915.
27. Schurmann M, Gradl G, Andress HJ, et al. Assessment of peripheral sympathetic nervous function for diagnosing early post-traumatic complex regional pain syndrome type I. Pain. 1999;80:149-159.
28. Wasner G, Heckmann K, Maier C, et al. Vascular abnormalities in acute reflex sympathetic dystrophy (CRPS I): complete inhibition of sympathetic nerve activity with recovery. Arch Neurol. 1999;56:613-620.
29. Wasner G, Baron R. Factor II: vasomotor changes, pathophisiology and measurement. In: Wilson PR, Stanton-Hicks R, Harden N, eds. CRPS: Current Diagnosis and Therapy. Progress in Pain Research and Management; v32. Seattle: IASP Press; 2005.
30. Wasner G, Schattschneider J, Heckmann K, et al. Vascular abnormalities in reflex sympathetic dystrophy (CRPS I): mechanisms and diagnostic value. Brain. 2001;124:587-599.
31. Howarth D, Burstal R, Hayes C, et al. Autonomic regulation of lymphatic flow in the lower extremity demonstrated on lymphoscintigraphy in patients with reflex sympathetic dystrophy. Clin Nucl Med. 1999;24:383-387.
32. Schurmann M, Zaspel J, Gradl G, et al. Assessment of the peripheral microcirculation using computer-assisted venous congestion plethysmography in post-traumatic complex regional pain syndrome type I. J Vasc Res. 2001;38:453-461.
33. Weber M, Birklein F, Neundorfer B, et al. Facilitated neurogenic inflammation in complex regional pain syndrome. Pain. 2001;91:251-257.
34. Leis S, Weber M, Isselmann A, et al. Substance-P-induced protein extravasation is bilaterally increased in complex regional pain syndrome. Exp Neurol. 2003;183:197-204.
35. Chemali KR, Gorodeski R, Chelimsky TC. Alpha-adrenergic supersensitivity of the sudomotor nerve in complex regional pain syndrome. Ann Neurol. 2001;49:453-459.
36. Saito K, Konishi S, Otsuka M. Antagonism between Lioresal and substance P in rat spinal cord. Brain Res. 1975;97:177-180.
37. Woolf C, Wiesenfeld-Hallin Z. Substance P and calcitonin gene-related peptide synergistically modulate the gain of the nociceptive flexor withdrawal reflex in the rat. Neurosci Lett. 1986;66:226-230.
38. Price DD, Long S, Wilsey B, et al. Analysis of peak magnitude and duration of analgesia produced by local anesthetics injected into sympathetic ganglia of complex regional pain syndrome patients. Clin J Pain. 1998;14:216-226.
39. van de Beek WJ, Vein A, Hilgevoord AA, et al. Neurophysiologic aspects of patients with generalized or multifocal tonic dystonia of reflex sympathetic dystrophy. J Clin Neurophysiol. 2002;19:77-83.
40. van Hilten JJ, Blumberg H, Schwartzman RJ. Factor IV: movement disorders and dystophy-pathophysiology and measurement. In: Wilson PR, Stanton-Hicks R, Harden N, eds. CRPS: Current Diagnosis and Therapy. Progress in Pain Research and Management; v32. Seattle: IASP press; 2005.
41. Schwenkreis P, Janssen F, Rommel O, et al. Bilateral motor cortex disinhibition in complex regional pain syndrome (CRPS) type I of the hand. Neurology. 2003;61:515-519.
42. Galer BS, Jensen M. Neglect-like symptoms in complex regional pain syndrome: results of a self-administered survey. J Pain Symptom Manage. 1999;18:213-217.
43. Schattschneider J, Wenzelburger R, Deuschl G, et al. Kinematic analysis of the upper extremity in CRPS. In: Harden RN, Baron R, Janig W, eds. Complex Regional Pain Syndrome, Progress in Pain Research and Management, v22. Seattle: IASP Press; 2001.
44. McCabe CS, Haigh RC, Ring EF, et al. A controlled pilot study of the utility of mirror visual feedback in the treatment of complex regional pain syndrome (type 1). Rheumatology (Oxford). 2003;42:97-101.
45. Galer BS, Henderson J, Perander J, et al. Course of symptoms and quality of life measurement in Complex Regional Pain Syndrome: a pilot survey. J Pain Symptom Manage. 2000;20: 286-292.
46. Tang NK, Wright KJ, Salkovskis PM. Prevalence and correlates of clinical insomnia co-occurring with chronic back pain. J Sleep Res. 2007;16:85-95.
47. Naughton F, Ashworth P, Skevington SM. Does sleep quality predict pain-related disability in chronic pain patients? The mediating roles of depression and pain severity 1. Pain. 2007;127:243-252.
48. Grigsby J, Rosenberg NL, Busenbark D. Chronic pain is associated with deficits in information processing. Percept Mot Skills. 1995;81:403-410.
49. Ling J, Campbell C, Heffernan TM, et al. Short-term prospective memory deficits in chronic back pain patients. Psychosom Med. 2007;69:144-148.
50. Dick BD, Rashiq S. Disruption of attention and working memory traces in individuals with chronic pain. Anesth Analg. 2007;104:1223-1229.
51. Apkarian AV, Sosa Y, Krauss BR, et al. Chronic pain patients are impaired on an emotional decision-making task. Pain. 2004;108:129-136.
52. Patil PG, Apfelbaum JL, Zacny JP. Effects of a cold-water stressor on psychomotor and cognitive functioning in humans. Physiol Behav. 1995;58:1281-1286.
53. Koffler SP, Hampstead BM, Irani F, et al. The neurocognitive effects of 5 day anesthetic ketamine for the treatment of refractory complex regional pain syndrome. Arch Clin Neuropsychol. 2007;22:719-729.
54. Correll GE, Maleki J, Gracely EJ, et al. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. Pain Med. 2004;5:263-275.
55. Goldberg ME, Domsky R, Scaringe D, et al. Multi-day low dose ketamine infusion for the treatment of complex regional pain syndrome. Pain Physician. 2005;8:175-179.
56. Kiefer RT, Rohr P, Ploppa A, et al. Complete recovery from intractable complex regional pain syndrome, CRPS-type I, following anesthetic ketamine and midazolam. Pain Pract. 2007;7:147-150.
57. Kiefer RT, Rohr P, Ploppa A, et al. Efficacy of ketamine in anesthetic dosage for the treatment of refractory Complex Regional Pain Syndrome (CRPS). Pain Med. 2008. [Feb 5 Epub ahead of print]. PMID: 18266808.
58. Rajkumar SV, Fonseca R, Witzig TE. Complete resolution of reflex sympathetic dystrophy with thalidomide treatment. Arch Intern Med. 2001;161:2502-2503.
59. Schwartzman RJ, Chevlen E, Bengtson K. Thalidomide has activity in treating complex regional pain syndrome. Arch Intern Med. 2003;163:1487-1488.
60. Schwartzman RJ, Irving G, Wallace M, et al. A Multicenter, Open Label, 12 Week Study With Extension to Evaluate the Safety and Efficacy of Lenalidomide (CC5013) in the Treatment of Complex Regional Pain Syndrome type-I. Abstract: 11th World Congress on Pain. Seattle: IASP Press; 2005:580.